Abstract

BackgroundExposure to organic dust causes detrimental airway inflammation. Current preventative and therapeutic measures do not adequately treat resulting disease, necessitating novel therapeutic interventions. Recently identified mediators derived from polyunsaturated fatty acids exhibit anti-inflammatory and pro-resolving actions. We tested the potential of one of these mediators, maresin-1 (MaR1), in reducing organic dust-associated airway inflammation.MethodsAs bronchial epithelial cells (BECs) are pivotal in initiating organic dust-induced inflammation, we investigated the in vitro effects of MaR1 on a human BEC cell line (BEAS-2B). Cells were pretreated for 1 hour with 0–200 nM MaR1, followed by 1–24 hour treatment with 5% hog confinement facility-derived organic dust extract (HDE). Alternatively, a mouse lung slice model was utilized in supportive cytokine studies. Supernatants were harvested and cytokine levels determined via enzyme-linked immunosorbent assays. Epithelial cell protein kinase C (PKC) isoforms α and ϵ, and PKA activities were assessed via radioactivity assays, and NFκB and MAPK-related signaling mechanisms were investigated using luciferase vector reporters.ResultsMaR1 dose-dependently reduced IL-6 and IL-8 production following HDE treatment of BECs. MaR1 also reduced HDE-stimulated cytokine release including TNF-α in a mouse lung slice model when given before or following HDE treatment. Previous studies have established that HDE sequentially activates epithelial PKCα and PKCϵ at 1 and 6 hours, respectively that regulated TNF-α, IL-6, and IL-8 release. MaR1 pretreatment abrogated these HDE-induced PKC activities. Furthermore, HDE treatment over a 24-hour period revealed temporal increases in NFκB, AP-1, SP-1, and SRE DNA binding activities, using luciferase reporter assays. MaR1 pretreatment did not alter the activation of NFκB, AP-1, or SP-1, but did reduce the activation of DNA binding at SRE.ConclusionsThese observations indicate a role for MaR1 in attenuating the pro-inflammatory responses of BECs to organic dust extract, through a mechanism that does not appear to rely on reduced NFκB, AP-1, or SP-1-related signaling, but may be mediated partly through SRE-related signaling. These data offer insights for a novel mechanistic action of MaR1 in bronchial epithelial cells, and support future in vivo studies to test MaR1’s utility in reducing the deleterious inflammatory effects of environmental dust exposures.

Highlights

  • Exposure to organic dust causes detrimental airway inflammation

  • In consideration of the important roles that Bronchial epithelial cell (BEC) play in potentiating the pro-inflammatory effects of hog confinement facility-derived organic dust extract (HDE), including the release of cytokines, in part through protein kinase C (PKC) isoform activation, and recruitment and activation of other leukocyte responders [7,24,25,26], the purpose of our study was to determine whether MaR1 would reduce the pro-inflammatory effects in BECs induced by HDE

  • MaR1 reduces the release of HDE-induced proinflammatory cytokines (IL-6 and IL-8) by airway epithelial cells (BEAS-2B cell line) Previous studies have shown treatment of BECs with 5% HDE for 24 hours leads to significant increases in IL-6 and IL-8 release [7,8]

Read more

Summary

Introduction

Exposure to organic dust causes detrimental airway inflammation. Current preventative and therapeutic measures do not adequately treat resulting disease, necessitating novel therapeutic interventions. We tested the potential of one of these mediators, maresin-1 (MaR1), in reducing organic dust-associated airway inflammation. Airway inflammation resulting from organic dust exposure is characterized by heightened pro-inflammatory cytokine release, neutrophil infiltration, and tissue remodeling processes. Long-term effects of chronic exposure include increased risk for lung function loss and obstructive pulmonary diseases [3]. Preventative measures such as the use of respirator masks to limit dust exposure are available, these measures are not widely adopted or consistently utilized amongst the exposed populations [4]. Improved preventative and therapeutic options are needed to assist this population of affected individuals

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.